Market Tracker

05/26 6:02pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

127.87
Delayed Data
As of May 26
 +3.06 / +2.45%
Today’s Change
51.93
Today|||52-Week Range
132.99
+31.82%
Year-to-Date

Today’s Trading

Previous close124.81
Today’s open124.03
Day’s range123.06 - 128.26
Volume1,363,240
Average volume (3 months)702,785
Market cap$10.5B
Dividend yield--
Data as of 3:59pm ET, 05/26/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+38.24%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book10.29

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-0.43-0.62%
ISISIsis Pharmaceuticals...-0.77-1.14%
ICLRICON PLC-1.08-1.62%
DYAXDyax Corp-0.51-1.91%
Data as of 4:03pm ET, 05/26/2015

Financials

Next reporting dateAugust 3, 2015
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts